1
Clinical Trials associated with ZG-002 (Shanghai Zhigen)评价ZG-002 片在健康受试者中单次和多次给药剂量递增的安全性、耐受性、药代动力学特征和食物影响的 I 期临床研究
[Translation] Phase I clinical study to evaluate the safety, tolerability, pharmacokinetic characteristics and food effects of single and multiple dose escalation of ZG-002 tablets in healthy subjects
(1)研究健康受试者单次口服不同剂量ZG-002片的耐受性及药代动力学;
(2)研究健康受试者多次口服不同剂量ZG-002片的耐受性及药代动力学;
(3)研究饮食对健康受试者口服ZG-002片药代动力学的影响。
[Translation] (1) To study the tolerability and pharmacokinetics of healthy subjects after single oral administration of different doses of ZG-002 tablets;
(2) To study the tolerability and pharmacokinetics of healthy subjects after multiple oral administration of different doses of ZG-002 tablets;
(3) To study the effect of diet on the pharmacokinetics of oral ZG-002 tablets in healthy subjects.
100 Clinical Results associated with ZG-002 (Shanghai Zhigen)
100 Translational Medicine associated with ZG-002 (Shanghai Zhigen)
100 Patents (Medical) associated with ZG-002 (Shanghai Zhigen)
100 Deals associated with ZG-002 (Shanghai Zhigen)